首页   >  
Ion Channel/Membrane Transporter
  >  
BCRP

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

BCRP

结构式 货号 产品名称 CAS号
Zamicastat 结构式
BCP33811 Zamicastat 1080028-80-3
Zamicastat is a dopamine β-hydroxylase (DBH) inhibitor that could cross the blood-brain barrier (BBB) and cause central as well as peripheral effects. Zamicastat is also a concentration-dependent dual P-gp and BCRP inhibitor with IC50 values of 73.8 μM and 17.0 μM, respectively. Reduces high blood pressure.
ML753286 结构式
BCP25916 ML753286 1699720-89-2
ML753286 is a potent inhibitor for BCRP, ML753286 has low to medium clearance in rodent and human liver S9 fractions, and is stable in plasma cross species.
Brevianamide F 结构式
BCP24252 Brevianamide F 38136-70-8
Brevianamide F is a naturally occurring 2,5-diketopiperazine that possess interesting breast cancer resistance protein (BCRP) inhibitory activity.; also shows agonism towards Ca(2+)-channel activity at 100 uM, and has potentiation for use in the treatment of cardiovascular dysfunction.
YHO-13177 结构式
BCP28922 YHO-13177 912287-56-0
YHO-13177 is a potent and specific inhibitor of breast cancer resistance protein (BCRP/ABCG2).
KS 176 结构式
BCP17744 KS 176 1253452-78-6
KS176 is a potent and selective inhibitor of the breast cancer resistance protein (BCRP) multidrug transporter (IC50 values are 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively). Displays no inhibitory activity against P-gp or MRP1.
YHO-13351 (free base) 结构式
BCP28919 YHO-13351 (free base) 912288-64-3
YHO-13351 (free base) is the water-soluble prodrug of YHO-13177, which is a potent and specific inhibitor of BCRP.
YHO-13351 结构式
BCP28920 YHO-13351 1346753-00-1
YHO-13351 is the water-soluble prodrug of YHO-13177, which is a potent and specific inhibitor of BCRP.
Fumitremorgin C 结构式
BCP28921 Fumitremorgin C 118974-02-0
Fumitremorgin C is a potent and selective ABCG2/BRCP inhibitor.
Elacridar 结构式
BCP05709 依克立达 143664-11-3
Elacridar is a P-glycoprotein and breast cancer resistance protein inhibitor that has been used to improve the brain distribution of drugs that are substrates of P-gp and BCRP.
Elacridar HCl 结构式
BCP14056 依克立达盐酸盐 143851-98-3
Elacridar hydrochloride (GF120918A) is a potent P-glycoprotein (Pgp) and BCRP inhibitor
12下一页共 11 条记录 1 / 2 页 
2853530911